PlainPharmaWatch

CMS Open Payments · Tool

Avadel CNS Pharmaceuticals, LLC vs Omnia Medical, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Omnia Medical, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,054, versus 441 for the other company. Its single largest recorded recipient represents 17.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Avadel CNS Pharmaceuticals, LLC
HHI 441 · top recipient 14.7%
Ranked #1,339 of 1,838 companies by HHI
Omnia Medical, LLC
HHI 1,054 · top recipient 17.8%
Ranked #1,007 of 1,838 companies by HHI

Payment Overview

Total Payments
$2.1M
% of Industry
0.0%
Transactions
9,583
Avg per Transaction
$214.93
Recipients
9,568
Avg per Recipient
$215.27
Payment Types
6
Top Payment Type
Honoraria
Company B

Omnia Medical, LLC

Total Payments
$2.0M
% of Industry
0.0%
Transactions
110
Avg per Transaction
$18.3K
Recipients
110
Avg per Recipient
$18.3K
Payment Types
3
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

Avadel CNS Pharmaceuticals, LLC vs Omnia Medical, LLC - total reported payments in CMS Open Payments PY2024

Avadel CNS Pharmaceuticals,…$2.1MOmnia Medical, LLC$2.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Avadel CNS Pharmaceuticals, LLC

Honoraria $781.7K

50.8%

Consulting Fee $293.4K

19.1%

Food and Beverage $244.2K

15.9%

Travel and Lodging $140.2K

9.1%

Compensation for Services Other Than Consulting $58.7K

3.8%

Education $20.7K

1.3%

Omnia Medical, LLC

Acquisitions $1.4M

68.8%

Royalty or License $530.1K

26.3%

Consulting Fee $99.1K

4.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Avadel CNS Pharmaceuticals, LLC

  1. 1

    JORDAN DUBOW

    $226,407.92 · 12 txns

  2. 2

    STEVEN GRADNEY

    $103,773.38 · 91 txns

  3. 3

    ALON AVIDAN

    $89,426.45 · 62 txns

  4. 4

    ANNE MORSE

    $80,890.69 · 59 txns

  5. 5

    MATTHEW DAVIS

    $63,773.26 · 71 txns

Omnia Medical, LLC

  1. 1

    JOHN MAIN

    $360,000.00 · 12 txns

  2. 2

    BRIAN SNELL

    $297,000.00 · 1 txns

  3. 3

    ANDREW PARKINSON

    $252,879.70 · 10 txns

  4. 4

    IAN JOHNSON

    $240,000.00 · 4 txns

  5. 5

    JUSTIN FIELD

    $168,833.36 · 7 txns

Summary Comparison

Metric Avadel CNS Pharmaceuticals, LLC Omnia Medical, LLC
Total Payments $2.1M $2.0M
% of Industry Total 0.0% 0.0%
Transaction Count 9,583 110
Avg per Transaction $214.93 $18.3K
Recipient Count 9,568 110
Avg per Recipient $215.27 $18.3K
Payment Type Count 6 3
Top Payment Type Honoraria Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.